Rivofonet Tablet

Rivofonet Tablet – Tenofovir disoproxil fumarate (300mg)

Rivofonet Tablet contains Tenofovir Disoproxil Fumarate 300mg, a nucleotide reverse transcriptase inhibitor (NtRTI) manufactured by Emcure Pharmaceuticals Ltd. It is used as part of combination antiretroviral therapy for HIV-1 infection and in the management of chronic Hepatitis B.

Key Features

• Single-agent NtRTI antiretroviral tablet, made by Emcure
• Contains Tenofovir Disoproxil Fumarate 300mg
• Used in combination ART regimens for HIV-1
• Also used in chronic Hepatitis B management
• Bottle of 30 tablets, Schedule H prescription drug

Composition

• Tenofovir disoproxil fumarate (300mg)

Uses & Benefits

• Used in combination with other antiretrovirals to treat HIV-1 infection
• Helps reduce HIV viral load as part of a broader ART regimen
• Used for management of chronic Hepatitis B virus infection
• Supports long-term suppression of viral replication

Directions for Use

• Take exactly as prescribed by your physician, alongside other prescribed medicines
• Usually taken once daily with food
• Swallow the tablet whole with water
• Do not skip doses to help prevent drug resistance

Precautions

• Use only under the supervision of a qualified physician
• Inform your doctor of any kidney or liver conditions before starting treatment
• Regular monitoring of blood counts, liver and kidney function may be required
• Inform your healthcare provider about all other medications you are taking
• Consult your doctor before use during pregnancy or breastfeeding
• Do not skip or stop doses without medical advice, as this may lead to drug resistance

Storage

• Store below 30°C in a cool, dry place
• Keep out of reach of children
• Protect from excessive heat and moisture

Disclaimer

This is a Schedule H prescription medicine. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change the dose without consulting a qualified healthcare provider.